Joint Corp (NASDAQ:JYNT) – Investment analysts at B. Riley issued their Q2 2020 earnings estimates for shares of Joint in a report issued on Tuesday, November 5th. B. Riley analyst J. Van. Sinderen expects that the company will post earnings per share of $0.05 for the quarter. B. Riley has a “Buy” rating and a $23.00 price objective on the stock. B. Riley also issued estimates for Joint’s Q3 2020 earnings at $0.06 EPS.
Joint (NASDAQ:JYNT) last announced its earnings results on Thursday, November 7th. The company reported $0.04 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.03 by $0.01. The company had revenue of $12.73 million for the quarter, compared to analyst estimates of $11.60 million. Joint had a return on equity of 114.93% and a net margin of 5.38%.
NASDAQ:JYNT opened at $19.15 on Friday. The company has a fifty day simple moving average of $18.82 and a two-hundred day simple moving average of $18.09. Joint has a 52 week low of $6.51 and a 52 week high of $21.80. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 3.33. The company has a market cap of $275.64 million, a price-to-earnings ratio of 478.75 and a beta of 1.01.
A number of hedge funds and other institutional investors have recently bought and sold shares of JYNT. Marshall Wace North America L.P. purchased a new position in Joint during the first quarter worth about $47,000. Strs Ohio purchased a new position in Joint during the second quarter worth about $63,000. Skylands Capital LLC raised its holdings in Joint by 4.4% during the second quarter. Skylands Capital LLC now owns 550,701 shares of the company’s stock worth $10,023,000 after purchasing an additional 23,051 shares in the last quarter. Wedge Capital Management L L P NC purchased a new position in Joint during the second quarter worth about $719,000. Finally, Wells Fargo & Company MN purchased a new position in Joint during the second quarter worth about $227,000. 64.45% of the stock is owned by hedge funds and other institutional investors.
The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates through two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and the sale of regional developer rights. As of March 07, 2019, the company operated 450 clinics in the United States.
Recommended Story: What are the benefits of buying treasury bonds?
Receive News & Ratings for Joint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint and related companies with MarketBeat.com's FREE daily email newsletter.